Alkem Laboratories Ltd has acquired a 100% stake in Adroit Biomed for ₹140 crore and a 100% stake in Bombay Ortho Industries for ₹147 crore to enhance its portfolio in the skincare and orthopedic segments.

Information on the Target

Alkem Laboratories Ltd has announced its acquisition of a 100% stake in Adroit Biomed Ltd., a pharmaceutical company specializing in the skincare segment, for approximately ₹140 crore. Adroit Biomed is recognized for its distinct dermatology portfolio, which includes prominent brands such as Glutone, SkinFay, Racine, and FortiSil. The company reported revenue growth from ₹48.14 crores in FY23 to ₹53.55 crores in FY24.

In addition, Alkem’s subsidiary, Alkem MedTech, has signed a binding offer to acquire a 100% stake in Bombay Ortho Industries Pvt Ltd for about ₹147 crore. Established in 2021, Bombay Ortho focuses on manufacturing hip and knee implants, making it a key player in India’s expanding medical device industry. The company's revenue surged from ₹30 lakhs in FY23 to ₹5.5 crores in FY24.

Industry Overview in India

The pharmaceutical and medical device industry in India has been experiencing significant growth, driven by increasing healthcare expenditures, a burgeoning population, and rising awareness regarding health and wellness. The